Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Navigating Human Astrocyte Differentiation: Direct and Rapid One-Step Differentiation of Induced Pluripotent Stem Cells to Functional Astrocytes Supporting Neuronal Network Development.

Glia·2026
Same author

Microaffirmations, counterspaces, and mental health: Supporting Black male students at Predominantly White Institutions.

Cultural diversity & ethnic minority psychology·2026
Same author

EpiATLAS - a reference for human epigenomic research.

bioRxiv : the preprint server for biology·2026
Same author

Comprehensive assessment of on- and off-target mutagenesis via lipid nanoparticle delivery of CRISPR-Cas9 genome editing.

Molecular therapy. Nucleic acids·2026
Same author

Pathological disruption of CELF2 shuttling causes neuronal hyperactivity, learning deficits, and seizures.

The Journal of clinical investigation·2026
Same author

An X-linked long non-coding RNA, PTCHD1-AS, and the core features of autism.

Nature·2026

Related Experiment Video

Updated: Jun 17, 2026

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

EOS lentiviral vector selection system for human induced pluripotent stem cells.

Akitsu Hotta1, Aaron Y L Cheung, Natalie Farra

  • 1Developmental and Stem Cell Biology Program, SickKids, Toronto, Ontario, Canada.

Nature Protocols
|December 17, 2009
PubMed
Summary

Generating induced pluripotent stem (iPS) cells is crucial for disease research and therapies. This study details a protocol for a lentiviral selection system to efficiently enrich for human iPS cells, overcoming reprogramming challenges.

More Related Videos

Transfection, Selection, and Colony-picking of Human Induced Pluripotent Stem Cells TALEN-targeted with a GFP Gene into the AAVS1 Safe Harbor
07:28

Transfection, Selection, and Colony-picking of Human Induced Pluripotent Stem Cells TALEN-targeted with a GFP Gene into the AAVS1 Safe Harbor

Published on: February 1, 2015

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector
12:03

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector

Published on: October 31, 2012

Related Experiment Videos

Last Updated: Jun 17, 2026

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

Transfection, Selection, and Colony-picking of Human Induced Pluripotent Stem Cells TALEN-targeted with a GFP Gene into the AAVS1 Safe Harbor
07:28

Transfection, Selection, and Colony-picking of Human Induced Pluripotent Stem Cells TALEN-targeted with a GFP Gene into the AAVS1 Safe Harbor

Published on: February 1, 2015

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector
12:03

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector

Published on: October 31, 2012

Area of Science:

  • Stem Cell Biology
  • Molecular Medicine
  • Biotechnology

Background:

  • Induced pluripotent stem (iPS) cells offer significant potential for disease modeling, drug screening, and regenerative medicine.
  • Low efficiency and heterogeneity in reprogramming hinder the generation of patient-specific iPS cell lines.
  • Previous work established the first selection system for enriched reprogrammed human iPS cells.

Purpose of the Study:

  • To provide a detailed protocol for producing a pluripotent state-specific lentiviral vector.
  • To describe a selection system for inducing healthy and disease-specific human iPS cells.
  • To improve the efficiency and consistency of human iPS cell generation.

Main Methods:

  • Development of a lentiviral vector expressing enhanced green fluorescence protein (eGFP) and puromycin resistance.
  • Utilizing the vector to mark and select for human iPS cell colonies expressing endogenous pluripotency markers.
  • Detailed protocol preparation for the lentiviral vector and selection system.

Main Results:

  • Successful development of a lentiviral selection system for enriched human iPS cells.
  • Demonstration of marking and enriching iPS cell colonies based on pluripotency markers.
  • Established protocol for efficient generation of iPS cells.

Conclusions:

  • The described protocol enables efficient production of the selection system in 2 weeks.
  • Human iPS cell generation using this system takes approximately 2 months.
  • This method facilitates the generation of personalized iPS cell lines for research and therapeutic applications.